Interpersonal Psychotherapy for Depressed Adolescents and Parents

Sponsor
New York State Psychiatric Institute (Other)
Overall Status
Completed
CT.gov ID
NCT00619411
Collaborator
Columbia University (Other)
10
1
18

Study Details

Study Description

Brief Summary

The purpose of this study is to examine the feasibility and acceptability of an adaptation of Interpersonal Psychotherapy for Depressed Adolescents (IPT-A) that includes greater and more structured involvement of the parents in the treatment.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Interpersonal Therapy for Depressed Adolescents & Parents
Phase 1

Detailed Description

Adolescent depression is a significant public health problem, and it increases the risk of poor psychosocial outcomes in adolescence and adulthood. Interpersonal Psychotherapy for Depressed Adolescents (IPT-A) has been found to be an effective treatment for reducing adolescents' depressive symptoms and improving their global and social functioning. The purpose of the current study is to examine the feasibility and acceptability of IPT-A when it is delivered with greater and more structured involvement of the parents in the treatment.

Participants will receive 15 weeks of Interpersonal Psychotherapy for Depressed Adolescents and Parents (IPT-AP). Eight the therapy sessions are conducted with the adolescent individually, two are with the parent(s) individually, and five are conducted with the adolescent and parent(s) together. At the end of the 15 weeks, participants who have demonstrated at least a 50% reduction in depressive symptoms will participate in three booster sessions delivered on a monthly basis. All participants will be assessed at baseline, week 5, week 10, week 15 (post-treatment), and 3 months post-treatment to measure depressive symptoms, global and social functioning, and attitudes toward treatment.

Study Design

Study Type:
Interventional
Actual Enrollment :
10 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
An Open Clinical Trial of Interpersonal Psychotherapy for Depressed Adolescence and Parents
Study Start Date :
Nov 1, 2007
Actual Primary Completion Date :
May 1, 2009
Actual Study Completion Date :
May 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: I

Behavioral: Interpersonal Therapy for Depressed Adolescents & Parents
15 weekly psychotherapy sessions

Outcome Measures

Primary Outcome Measures

  1. Clinical Global Improvement (CGI), Hamilton Rating Scale for Depression (HRSD), Center for Epidemiological Studies - Depression Scale (CES-D) [baseline, week 5, 10, 15]

Secondary Outcome Measures

  1. Global Assessment Scale for Children (C-GAS), Social Adjustment Scale - Self-report (SAS-SR), Conflict Behavior Questionnaire (CBQ-20), Observational assessment of parent-adolescent communication [baseline, week 5, 10, 15]

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Meets diagnostic criteria for major depression, dysthymic disorder, depressive disorder not otherwise specified, or adjustment disorder with depressed mood

  • Score between 10 and 28 on the HRSD

  • Score of 65 or less on the C-GAS

  • English-speaking adolescent

  • Parental or legal guardian consent to participate

Exclusion Criteria:
  • Actively suicidal

  • Score greater than 28 on the HRSD

  • Mentally retarded

  • Meets diagnostic criteria for current substance abuse, schizophrenia, bipolar disorder, psychosis, conduct disorder, or eating disorder

  • Currently in active treatment for depression

  • Taking antidepressant medication at the time of baseline assessment

  • Medical illness likely to complicate or interfere with treatment

  • Victim of ongoing or previously undisclosed child abuse

  • Parent psychiatrically hospitalized within the past 3 months

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • New York State Psychiatric Institute
  • Columbia University

Investigators

  • Principal Investigator: Meredith Gunlicks-Stoessel, Ph.D., University of Minnesota

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
New York State Psychiatric Institute
ClinicalTrials.gov Identifier:
NCT00619411
Other Study ID Numbers:
  • 5549
First Posted:
Feb 21, 2008
Last Update Posted:
Mar 9, 2012
Last Verified:
Mar 1, 2012

Study Results

No Results Posted as of Mar 9, 2012